(MENAFN- GlobeNewsWire - Nasdaq) The global ophthalmology market offers opportunities driven by increasing disease prevalence, technological advances like AI, and policy shifts. Key opportunities include personalized diagnostic and treatment options, fast-tracked innovations, and strategic alliances to accelerate growth and distribution.Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmology Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets's offering.
The global ophthalmology market is evolving rapidly, shaped by emerging patient needs, technological progress, and shifting policy landscapes. Senior healthcare leaders require clear, actionable insights to navigate these complexities and position their organizations for sustained growth.
![]()
Market Snapshot: Global Ophthalmology Market in Focus
The ophthalmology market is advancing from USD 63.71 billion in 2024 to USD 67.85 billion in 2025, with projections highlighting continued expansion at a CAGR of 6.76% through 2030 and a forecasted market size of USD 94.36 billion. This growth is powered by demographic trends, strong uptake of diagnostic and therapeutic technologies, and dynamic policy responses globally. The sector's robust outlook reflects not only increased disease prevalence but also heightened expectations for personalized and data-driven care across major regional markets.
Scope & Segmentation of the Ophthalmology Market
This comprehensive report offers detailed segmentation and in-depth analysis across all significant components of the ophthalmology sector. Market coverage encompasses a spectrum of products, technologies, and regions to aid in precise targeting and informed investment.
Product Types: Pharmaceuticals: For allergic conjunctivitis and inflammation, dry eye, glaucoma, and retinal disorders Diagnostic Devices: Fundus cameras, slit lamps, and ultrasound imaging systems Surgical Devices: Ophthalmic lasers and viscosurgical instruments Others: Prescription glasses and lenses
Ophthalmology Software: Data management applications, medical imaging platforms, and practice management tools. Disease Types: Age-related macular degeneration, cataract, glaucoma, inflammatory diseases, and refractive disorders. End Users: Healthcare service providers, hospitals, medical institutes, research organizations. Distribution Channels: Hospital pharmacies, online retail-including e-commerce platforms and manufacturer websites-retail pharmacies. Regions: Americas: Including North America (United States, Canada, Mexico) and Latin America (Brazil, Argentina, Chile, Colombia, Peru) Europe, Middle East & Africa: United Kingdom, Germany, France, Saudi Arabia, South Africa Asia-Pacific: Including China, India, Japan, Australia, South Korea, Indonesia, Singapore, Taiwan
Key Takeaways for Senior Decision-Makers
Bespoke diagnostic and treatment options are becoming standard, supporting superior outcomes and new revenue streams for healthcare providers. Artificial intelligence is transforming early detection, clinical workflow integration, and patient engagement across care pathways. Regulatory bodies are adapting to fast-track innovations, increasing market access for novel pharmaceuticals, surgical devices, and remote care solutions. Strategic alliances between pharmaceutical, device, and digital health companies are speeding up commercialization and geographic expansion. Supply chain strategies must address heightened volatility and regional requirements for pricing and fulfillment.
Why This Report Matters: Strategic Advantages Delivered
Enables executive teams to identify strategic partnerships, technology investments, and expansion opportunities across all major regions. Equips stakeholders to adapt to shifting policy, regulatory, and supply chain environments, supporting better planning and operational agility.
Conclusion
This report delivers in-depth, actionable intelligence for leaders aiming to capture growth, mitigate risks, and drive sustained innovation in ophthalmology. Decision-makers are empowered to anticipate trends and secure competitive advantages in a fast-changing sector.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 196 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value (USD) in 2025 | $67.85 Billion |
| Forecasted Market Value (USD) by 2030 | $94.36 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
Companies Featured
The companies profiled in this Ophthalmology market report include:
Alcon Inc. Bausch + Lomb Corporation Carl Zeiss AG AbbVie Inc. Alkeus Pharmaceuticals, Inc. Johnson & Johnson Services Inc. EssilorLuxottica S.A. Apotex Inc. ClearSight LLC by Riskonnect Duopharma Biotech Berhad Essex Bio-Technology Limited Eyenovia, Inc. F. Hoffmann-La Roche AG GenSight Biologics S.A. Glaukos Corporation Halma PLC Harrow Health, Inc. Hoya Corporation Kubota Pharmaceutical Holdings Co., Ltd. Lumenis Be Ltd. Nidek Co., Ltd. Novartis AG OCuSOFT, Inc. Oxurion NV Pfizer, Inc. Reichert by AMETEK, Inc. Santen Pharmaceutical Co., Ltd. SEED Co., Ltd. Sun Pharmaceutical Industries Limited Teva Pharmaceutical Industries Ltd. The Cooper Companies, Inc. Topcon Corporation Unimed Pharma, Spols r.o. Ziemer Ophthalmic Systems AG McKesson Corporation TME Pharma N.V. C.H. Boehringer Sohn AG & Co. KG
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
![]()
MENAFN08122025004107003653ID1110453172
Comments
No comment